Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma

Volume Two: Diagnosis, Therapeutic Targets and Molecular Mechanisms for Hepatocellular Carcinoma Progression

Author: Ganji Purnachandra Nagaraju

Published by: Elsevier Science

Publication Date: April 2, 2022

Language: English

ISBN: 9780323988070, 9780323993654

Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume Two provides comprehensive information about ongoing research and clinical data surrounding liver cancer. The book presents detailed descriptions about diagnostics and therapeutic options for easy understanding, with a focus on precision medicine approaches to improve treatment outcomes.

Diagnostics and Therapeutic Options

The volume discusses topics such as computational approaches for identification of biomarkers, enzymes and pathways of HCC, circulating and epigenetic biomarkers, drug resistance, metabolic pathways, and small molecule-target therapies. In addition, it discusses immunotherapies, immune check point inhibitors and nanotechnology-based therapies.

Target Audience

This book is a valuable resource for cancer researchers, oncologists, graduate students, hepathologists and members of biomedical research who need to understand more about liver cancer to apply in their research work or clinical setting.

Key Features

Provides detailed information on traditional and novel diagnostic tools for hepatocellular carcinoma

Discusses promising targeted therapies, both available and in development, explaining the best option to use for specific cases

Brings recent findings in immunotherapies, immune checkpoint inhibitors and nanotechnology-based therapeutic approaches for treatment of HCC